CERVOMED INC. - COMMON

12,53

07-ноября-24 15:59:45

15 мин. задержка

Акции

-0,31

-2,41%

Сегодняшний диапазон

12,43 - 13,30

ISIN

N/A

Источник

NASDAQ

CervoMed Announces Presentation of Biomarker Data from the AscenD-LB Phase 2a Trial and Preclinical Data Supporting Potential of Neflamapimod in Tau-Mediated Disease at AD/PD ™ 2024

05 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire
CervoMed to Participate in the BIO CEO and Investor Conference

21 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire
CervoMed Publishes Positive Results from AscenD-LB Phase 2a Trial in Peer-Reviewed Journal that Supports the Therapeutic Potential of Neflamapimod in Dementia with Lewy Bodies

12 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board

07 фев 2024 08:30:00 Источник Nasdaq GlobeNewswire
CervoMed to Participate in the Emerging Growth Conference 67

05 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire
CervoMed to Participate in the Emerging Growth Conference 66

05 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.